Pharmafile Logo

6 trends shaping the future of personalized medicine

Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators.

With precision medicines accounting for at least 25% of FDA approvals in the last 7 years, personalized healthcare is far from niche. Personalization is one of the foundations of modern healthcare, advancing how we realize better outcomes for patients and society.

Related forces like value-based care and patient empowerment are bolstering the movement towards personalization. At the same time, the COVID-19 pandemic has disrupted the health landscape—illuminating inequities, spurring technological innovation, and further elevating the role of human behavior in health.

Bringing together a wide array of stakeholders—from the pharmaceutical and diagnostic industry to providers, payers, patients, and clinicians—is crucial for exchanging perspectives and ideas in this changing landscape. This is just what the Personalized Medicine Coalition did at its 16th annual conference, “From an Enterprise to an Era,” in May.

Read on for our key takeaways from the rich conversations at the conference and learn what they mean for innovators working to continue advancing personalized healthcare.

DOWNLOAD THE FULL ARTICLE HERE

This content was provided by Avalere Health

Company Details

 Latest Content from  Avalere Health 

What does the future hold for Medical Affairs?

Lori Lush, Head of Fishawack Medical, reveals why she’s driven to tell impactful scientific stories, the benefits of cross-functional collaboration, and the trends she predicts for the next five years.

Unpacking rare diseases in the first edition of Delta magazine

Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization.

Fishawack Health unveils an unrivaled global market access and HEOR offering with the acquisition of PRMA Consulting

Fishawack Health bolsters its strong strategic offering by acquiring PRMA Consulting – a global market access and HEOR consulting leader with significant expertise in US, EU, and Asia-Pacific markets

Fishawack acquires creative consultancy Blue Latitude Health

The Fishawack Group has acquired Blue Latitude Health, based in London, UK, and New York, USA. Blue Latitude Health is a creative consultancy combining the commercial focus of a consultancy...

Fishawack launches new website and introduces new structure for growth

The Fishawack Group has launched their new website, introducing the company’s new two-division structure, Fishawack Medical Communications and Fishawack Creative. The new site showcases the Group's capabilities as well as...